SEC Info - Hancock John Financial Services Inc. - ‘4’ for 10/23/02 re: Nexell Therapeutics Inc.

SEC Info℠

Home

Help

Please Sign In

Hancock John Financial Services Inc. – ‘4’ for 10/23/02 re: Nexell Therapeutics Inc.

On: Friday, 10/25/02, at 2:04pm ET · For: 10/23/02 · Accession #: 1145443-2-602 · File #: 0-19153

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/25/02  Hancock John Fin’l Services Inc.  4          10% Owner   1:12K  Nexell Therapeutics Inc.          Digital Publishi… Inc/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of        6±    24K 
                Securities by an Insider                                         

4 1st “Page” of 3 TOC ↑Top Previous Next ↓Bottom Just 1st
 
                                                    ----------------------------
                                                  OMB APPROVAL
                                                  ------------
                                                    OMB Number:        3235-0287
                                                    Expires:    January 31, 2005
                                                Estimated average burden
                                                    hours per response ..... 0.5
                                                    ----------------------------

Form 4                                                                          

U. S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

 Filed pursuant to Section 16(a) of the Securities Exchange Act of
1934, Section 17(a) of the Public Utility Holding Company Act of
 1935 or Section 30(h) of the Investment Company Act of 1940

|X|   Check this box if no longer subject to Section 16. Form 4 or Form 5       
obligations may continue. See Instruction 1(b).                     

================================================================================
1. Name and Address of Reporting Person.*                                       

John Hancock Financial Services, Inc. (1)                                 
--------------------------------------------------------------------------------
(Last)               (First)                 (Middle)                     

P. O. Box 111                                                             
--------------------------------------------------------------------------------
(Street)                          

Boston, MA 02117                                                          
--------------------------------------------------------------------------------
(City)               (State)                 (Zip)                        

================================================================================
2. Issuer Name and Ticker or Trading Symbol                                     

Nexell Therapeutics, Inc. ("NEXL")                                        
================================================================================
3. I.R.S. Identification Number of Reporting Person, if an entity (Voluntary)   

04-348-3032                                                               
================================================================================
4. Statement for Month/Day/Year                                                 

October 23, 2002                                                          
================================================================================
5. If Amendment, Date of Original (Month/Day/Year)                              

================================================================================
6. Relationship of Reporting Person(s) to Issuer                                
(Check all applicable)                                                    

|_|   Director                             |X|   10% Owner                
|_|   Officer (give title below)           |_|   Other (specify below)    

================================================================================
7. Individual or Joint/Group Filing (Check Applicable Line)                     

|_|   Form filed by One Reporting Person                                  
|X|   Form filed by More than One Reporting Person                        

================================================================================

================================================================================
 Table I -- Non-Derivative Securities Acquired, Disposed of,
 or Beneficially Owned
================================================================================

                                                        [Enlarge/Download Table]

                                                                                            5.                                      
                                                                                            Amount of       6.                      
                                                             4.                             Securities      Owner-                  
                                     2A.                     Securities Acquired (A)        Beneficially    ship                    
                                     Deemed     3.           or Disposed of (D)             Owned           Form:      7.           
                                     Execution  Transaction  (Instr. 3, 4 and 5)            Following       Direct     Nature of    
                   2.                Date, if   Code         ----------------------------   Reported        (D) or     Indirect     
1.                 Transaction       any        (Instr. 8)                   (A)            Transaction(s)  Indirect   Beneficial   
Title of Security  Date              (Month/    ------------     Amount      or     Price   (Instr. 3       (I)        Ownership    
(Instr. 3)         (Month/Day/Year)  Day/Year)   Code     V                  (D)            and 4)          (Instr. 4) (Instr. 4)   
------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                                    

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

Reminder: Report on a separate line for each class of securities beneficially   
owned directly or indirectly.                                                   

* If the form is filed by more than one reporting person, see Instruction       
4(b)(v).                                                                        

Persons who respond to the collection of information contained in this form are 
not required to respond unless the form displays a currently valid OMB control  
number.                                                                         

                                                        (Over)
                                                                 SEC 1474 (9-02)

 Page 1 of 3

4 2nd “Page” of 3 TOC 1st Previous Next ↓Bottom Just 2nd
FORM 4 (continued)                                                              

Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

================================================================================

                                                        [Enlarge/Download Table]

                                                                                                          9.                        
                                                                                                          Number                    
                                                                                                          of        10.             
         2.                                                                                               Deriv-    Owner-          
         Con-                                                                                             ative     ship            
         ver-                             5.                                 7.                           Secur-    Form of  11.    
         sion                             Number of                          Title and Amount             ities     Deriv-   Nature 
         or              3A.              Derivative     6.                  of Underlying      8.        Bene-     ative    of     
         Exer-           Deemed  4.       Securities     Date                Securities         Price     ficially  Secu-    In-    
1.       cise   3.       Exe-    Trans-   Acquired (A)   Exercisable and     (Instr. 3 and 4)   of        Owned     rity;    direct 
Title of Price  Trans-   cution  action   or Disposed    Expiration Date     ----------------   Deriv-    Following Direct   Bene-  
Deriv-   of     action   Date,   Code     of (D)         (Month/Day/Year)            Amount     ative     Reported  (D) or   ficial 
ative    Deriv- Date     if any  (Instr.  (Instr. 3,     -----------------           or         Secur-    Trans-    Indirect Owner- 
Security ative  (Month/  (Month/ 8)       4 and 5)       Date      Expira-           Number     ity       action(s) (I)      ship   
(Instr.  Secur- Day/     Day/    -------  ------------   Exer-     tion              of         (Instr.   (Instr.   (Instr.  (Instr.
3)       ity    Year)    Year)   Code V   (A) (D)        cisable   Date      Title   Shares     5)        4)        4)       4)     
------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                                    
------------------------------------------------------------------------------------------------------------------------------------
Series B        10/23/02         S            30,000     11/24/99            Common  2,935,995  $1,153.32  -0-      I        (2)    
Cumula-                                                                      Stock                                                  
tive                                                                                                                                
Convert-                                                                                                                            
ible                                                                                                                                
Pre-                                                                                                                                
ferred                                                                                                                              
Stock                                                                                                                               
------------------------------------------------------------------------------------------------------------------------------------
Series B        10/23/02         S            2,000      11/24/99            Common  195,733    $1,153.32  -0-      I        (3)    
Cumula-                                                                      Stock                                                  
tive                                                                                                                                
Convert-                                                                                                                            
ible                                                                                                                                
Pre-                                                                                                                                
ferred                                                                                                                              
Stock                                                                                                                               
------------------------------------------------------------------------------------------------------------------------------------
Series B        10/23/02         S            1,000      11/24/99            Common  97,867     $1,153.32  -0-      I        (4)    
Cumula-                                                                      Stock                                                  
tive                                                                                                                                
Convert-                                                                                                                            
ible                                                                                                                                
Pre-                                                                                                                                
ferred                                                                                                                              
Stock                                                                                                                               
------------------------------------------------------------------------------------------------------------------------------------
Class B         10/23/02         J(5)         357,142.75 11/24/99  12/16/04  Common  385,088(6) (5)        -0-      I        (2)    
Warrant                                                                      Stock                                                  
to                                                                                                                                  
Purchase                                                                                                                            
------------------------------------------------------------------------------------------------------------------------------------
Class B         10/23/02         J(5)         23,809.5   11/24/99  12/16/04  Common  25,673(6)  (5)        -0-      I        (3)    
Warrant                                                                      Stock                                                  
to                                                                                                                                  
Purchase                                                                                                                            
------------------------------------------------------------------------------------------------------------------------------------
Class B         10/23/02         J(5)         11,904.75  11/24/99  12/16/04  Common  12,836(6)  (5)        -0-      I        (4)    
Warrant                                                                      Stock                                                  
to                                                                                                                                  
Purchase                                                                                                                            
------------------------------------------------------------------------------------------------------------------------------------
Class A         10/23/02         J(5)         714,285.5  11/24/04  12/16/04  Common  770,176(6) (5)        -0-      I        (2)    
Warrant                                                                      Stock                                                  
to                                                                                                                                  
Purchase                                                                                                                            
------------------------------------------------------------------------------------------------------------------------------------
Class A         10/23/02         J(5)         47,619     11/24/04  12/16/04  Common  51,346(6)  (5)        -0-      I        (3)    
Warrant                                                                      Stock                                                  
to                                                                                                                                  
Purchase                                                                                                                            
------------------------------------------------------------------------------------------------------------------------------------
Class A         10/23/02         J(5)         23,809.5   11/24/04  12/16/04  Common  25,672(6)  (5)        -0-      I        (4)    
Warrant                                                                      Stock                                                  
to                                                                                                                                  
Purchase                                                                                                                            
------------------------------------------------------------------------------------------------------------------------------------

Explanation of Responses:                                                       

(1) The Reporting Persons are as follows: John Hancock Financial Services, Inc. 
("JHFS"), JHFS's direct wholly-owned subsidiary John Hancock Life Insurance     
Company ("JHLICO"), JHLICO's direct wholly-owned subsidiary, John Hancock       
Variable Life Insurance Company ("JHVLICO") and JHVLICO's direct wholly-owned   
subsidiary, Investors Partner Life Insurance Company ("Partner"). See attached  
Joint Filer Information.                                                        

(2) JHLICO is a direct, wholly-owned subsidiary of JHFS. JHFS may be deemed the 
indirect beneficial owner of securities beneficially owned by JHLICO.           

(3) Directly owned by JHVLICO. These securities may be deemed beneficially owned
indirectly by JHFS and JHLICO.                                                  

(4) Directly owned by Partner. These securities may be deemed beneficially owned
indirectly by JHFS, JHLICO and JHVLICO.                                         

(5) The Class A Warrants and Class B Warrants were sold with the Convertible    
Preferred Stock. All of the consideration for the warrants and the Convertible  
Preferred Stock was attributed to the Convertible Preferred Stock.              

(6) These figures are based on the Issuer's 10-K dated December 31, 2001, which 
reports a slight anti-dilution adjustment.                                      

     /s/ James E. Collins                           October 25, 2002
-----------------------------------------------     ----------------------------
**  James E. Collins                                            Date            
Vice President and Corporate Secretary                                  

**  Intentional misstatements or omissions of facts constitute Federal          
Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).          

Note: File three copies of this Form, one of which must be manually signed. If  
space is insufficient, see Instruction 6 for procedure.                         

Potential persons who are to respond to the collection of information contained 
in this form are not required to respond unless the form displays a currently   
valid OMB Number.                                                               

 Page 2 of 3

4 Last “Page” of 3 TOC 1st Previous Next ↓Bottom Just 3rd
 Joint Filer Information

Issuer Name and Trading Symbol:    Nexell Therapeutics, Inc.  ("NEXL")          

Statement for:                     October 23, 2002                             

Designated Reporter:               John Hancock Financial Services, Inc.        

                                                        [Enlarge/Download Table]
                                                                                         
1. Name and address of Reporting Person:         Name and address of Reporting Person:   

   John Hancock Life Insurance Company           Investors Partner Life Insurance Company
   200 Clarendon Street                          200 Clarendon Street                    
   Boston, MA 02117                              Boston, MA 02117                        

   IRS Number:  04-1414660                       IRS Number:  13-3072894                 

   By:    Stephen J. Blewitt                     By:     /s/ Stephen J. Blewitt          
       -------------------------                       ---------------------------       
       Stephen J. Blewitt                              Stephen J. Blewitt                
       Authorized Signatory                            Authorized Signatory              

3. Name and address of Reporting Person:                                                 

   John Hancock Variable Life Insurance Company                                          
   200 Clarendon Street                                                                  
   Boston, MA 02117                                                                      

   IRS Number:  04-2664016                                                               

   By:   /s/ Stephen J. Blewitt                                                          
       -------------------------                                                         
       Stephen J. Blewitt                                                                
       Authorized Signatory                                                              

 Page 3 of 3

4	1st “Page” of 3	TOC	↑Top	Previous	Next	↓Bottom	Just 1st

4	2nd “Page” of 3	TOC	1st	Previous	Next	↓Bottom	Just 2nd

4	Last “Page” of 3	TOC	1st	Previous	Next	↓Bottom	Just 3rd

Dates Referenced Herein and Documents Incorporated by Reference

		Referenced-On Page
This ‘4’ Filing	Date	First	Last	Other Filings

	1/31/05	1
Filed on:	10/25/02	2		8-K
For Period end:	10/23/02	1	3
	12/31/01	2		10-K, 10-K/A, 10-K405, 11-K, ARS
				List all Filings

↑Top

Filing Submission 0001145443-02-000602 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Hancock John Financial Services Inc. – ‘4’ for 10/23/02 re: Nexell Therapeutics Inc.

On: Friday, 10/25/02, at 2:04pm ET · For: 10/23/02 · Accession #: 1145443-2-602 · File #: 0-19153

Previous ‘4’: ‘4’ on 9/5/02 for 9/4/02 · Next: ‘4’ on 11/6/02 for 11/4/02 · Latest: ‘4’ on 7/7/04 for 11/6/03

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34Filing Table of Contents

Dates Referenced Herein and Documents Incorporated by Reference

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34
Filing Table of Contents